HOME >> BIOLOGY >> NEWS
New science of metagenomics 'will transform modern microbiology'

WASHINGTON -- The emerging field of metagenomics, where the DNA of entire communities of microbes is studied simultaneously, presents the greatest opportunity -- perhaps since the invention of the microscope -- to revolutionize understanding of the microbial world, says a new report from the National Research Council. The report calls for a new Global Metagenomics Initiative to drive advances in the field in the same way that the Human Genome Project advanced the mapping of our genetic code.

Microorganisms are essential to life on Earth, transforming key elements into energy, maintaining the chemical balance in the atmosphere, providing plants and animals with nutrients, and performing other functions necessary for survival. There are billions of benign microbes in the human body, for example, that help to digest food, break down toxins, and fight off disease-causing microbes. Microbes are used commercially for many purposes, including making antibiotics, remediating oil spills, enhancing crop production, and producing biofuels.

Historically, microbiology focused on the study of individual species of organisms that could be grown in a laboratory and examined under a microscope, but most of the life-supporting activities of microbes are carried out by complex communities of microorganisms, and many cannot be grown in laboratory culture. Metagenomics will transform modern microbiology by giving scientists the tools to study entire communities of microbes -- the vast majority of which are likely to be previously unknown species that cannot be cultured -- and how they interact to perform such functions as balancing the atmosphere's composition, fighting disease, and supporting plant growth, the new report says.

"Metagenomics lets us see into the previously invisible microbial world, opening a frontier of science that was unimaginable until recently," said Jo Handelsman, Howard Hughes Medical Institute Professor, departments of plant
'"/>

Contact: William Kearney
news@nas.edu
202-334-2138
The National Academies
27-Mar-2007


Page: 1 2 3 4

Related biology news :

1. AFCYBER holds science and technology symposium
2. News tips from the Journal of Neuroscience
3. Neurosciences and music meet in Montreal
4. 47th Interscience Conference on Antimicrobial Agents and Chemotherapy
5. News tips from the Journal of Neuroscience
6. Nottingham biosciences million pound injection
7. News tips from the Journal of Neuroscience
8. A novel molecular dictator with a conscience discovered
9. News tips from the Journal of Neuroscience
10. Bulls-eye -- Programs targeting math, science teacher shortage may get boost
11. New ACS podcast debuts with science news for broad general audience

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/3/2017)...  Data captured by IsoCode, IsoPlexis Corporation,s ... statistically significant association between the potency of ... objective response of cancer patients post-treatment. The ... cancer patients will respond to CAR-T cell ... to improve both pre-infusion potency testing and cell ...
(Date:3/29/2017)... -- higi, the health IT company that operates the largest ... , today announced a Series B investment from BlueCross ... new investment and acquisition accelerates higi,s strategy to create ... health activities through the collection and workflow integration of ... and secures data today on behalf of over 36 ...
(Date:3/24/2017)... Research and Markets has announced the addition of the ... Industry Forecast to 2025" report to their offering. ... The Global Biometric Vehicle Access ... 15.1% over the next decade to reach approximately $1,580 million by ... and forecasts for all the given segments on global as well ...
Breaking Biology News(10 mins):
(Date:10/11/2017)... ... October 11, 2017 , ... ... its endogenous context, enabling overexpression experiments and avoiding the use of exogenous expression ... guides is transformative for performing systematic gain-of-function studies. , This complement to ...
(Date:10/11/2017)... the Netherlands and LAGUNA HILLS, Calif. ... The Institute of Cancer Research, London ... use MMprofiler™ with SKY92, SkylineDx,s prognostic tool to risk-stratify patients ... trial known as MUK nine . The University of ... trial, which is partly funded by Myeloma UK, and ICR ...
(Date:10/10/2017)... CA (PRWEB) , ... October ... ... a development-stage cancer-focused pharmaceutical company advancing targeted antibody-drug conjugate (ADC) therapeutics, today ... of targeted HPLN (Hybrid Polymerized Liposomal Nanoparticle), a technology developed in collaboration ...
(Date:10/10/2017)... ... October 10, 2017 , ... USDM Life ... for the life sciences and healthcare industries, announces a presentation by Subbu Viswanathan ... The presentation, “Automating GxP Validation for Agile Cloud Platforms,” will present a revolutionary ...
Breaking Biology Technology:
Cached News: